Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125326881 | 12532688 | 1 | I | 201601 | 20160616 | 20160706 | 20160706 | PER | US-ACTELION-A-US2016-138339 | ACTELION | 70.00 | YR | E | F | Y | 0.00000 | 20160706 | MD | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125326881 | 12532688 | 1 | PS | TRACLEER | BOSENTAN | 1 | Oral | 125 MG, BID | 21290 | 125 | MG | TABLET | BID | ||||||
125326881 | 12532688 | 2 | C | ADCIRCA | TADALAFIL | 1 | U | 0 | |||||||||||
125326881 | 12532688 | 3 | C | SYSTANE (HYPROMELLOSE 2910 (4000 MPA.S)) | HYPROMELLOSE 2910 (4000 MPA.S) | 1 | U | 0 | |||||||||||
125326881 | 12532688 | 4 | C | LOTEMAX | LOTEPREDNOL ETABONATE | 1 | U | 0 | |||||||||||
125326881 | 12532688 | 5 | C | NAPROXEN. | NAPROXEN | 1 | U | 0 | |||||||||||
125326881 | 12532688 | 6 | C | MAGNESIUM OXIDE. | MAGNESIUM OXIDE | 1 | U | 0 | |||||||||||
125326881 | 12532688 | 7 | C | ALPRAZOLAM. | ALPRAZOLAM | 1 | U | 0 | |||||||||||
125326881 | 12532688 | 8 | C | VISTARIL | HYDROXYZINE PAMOATE | 1 | U | 0 | |||||||||||
125326881 | 12532688 | 9 | C | MELATONIN | MELATONIN | 1 | U | 0 | |||||||||||
125326881 | 12532688 | 10 | C | POTASSIUM | POTASSIUM | 1 | U | 0 | |||||||||||
125326881 | 12532688 | 11 | C | ZYRTEC | CETIRIZINE HYDROCHLORIDE | 1 | U | 0 | |||||||||||
125326881 | 12532688 | 12 | C | PENTOXIFYLLINE. | PENTOXIFYLLINE | 1 | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125326881 | 12532688 | 1 | Pulmonary arterial hypertension |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125326881 | 12532688 | Condition aggravated | |
125326881 | 12532688 | Headache | |
125326881 | 12532688 | Pulmonary arterial hypertension | |
125326881 | 12532688 | Vision blurred |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |